Deep Blue Medical Advances
Durham, US · Founded 2015 · Delaware corporation
Founders & leadership
WP
William PerryExecutive
HL
Howard LevinsonNamed on SEC filing
KG
Ken GallNamed on SEC filing
RI
Robert IsaacsNamed on SEC filing
Board
MB
Michael BatesBoard director
NM
Neil MeyerBoard director
BD
Brent DuncanBoard director
RB
Robert BonczekBoard director
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 6 rounds · 2017–2025
▶$5.3MraisedSep 2025 · 105 investors · BiotechnologyRule 506(b)
▶$5.3MraisedSep 2025 · 105 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard LevinsonExecutive Officer, Director
- William PerryExecutive Officer, Director
- Michael BatesDirector
- Neil MeyerDirector
- Brent DuncanDirector
- Offering amount
- $5.7M
- Amount sold
- $5.3M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJun 2022 · 113 investors · BiotechnologyRule 506(b)
▶$7MraisedJun 2022 · 113 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BatesDirector
- Ken GallDirector
- William PerryExecutive Officer, Director, Promoter
- Howard LevinsonExecutive Officer, Director, Promoter
- Brent DuncanDirector
- Offering amount
- $7.5M
- Amount sold
- $7M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedFeb 2021 · 106 investors · BiotechnologyRule 506(b)
▶$3.4MraisedFeb 2021 · 106 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BatesDirector
- Howard LevinsonExecutive Officer, Director, Promoter
- William PerryExecutive Officer, Director, Promoter
- Ken GallDirector
- Offering amount
- $3.5M
- Amount sold
- $3.4M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJan 2021 · 73 investors · BiotechnologyRule 506(b)
▶$1.6MraisedJan 2021 · 73 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ken GallDirector
- Michael BatesDirector
- Brent DuncanDirector
- Howard LevinsonExecutive Officer, Director, Promoter
- William PerryExecutive Officer, Director, Promoter
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$295KraisedAug 2018 · 18 investors · BiotechnologyRule 506(b)
▶$295KraisedAug 2018 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William PerryExecutive Officer, Director, Promoter
- Robert IsaacsDirector
- Howard LevinsonExecutive Officer, Director, Promoter
- Robert BonczekDirector
- Ken GallDirector
- Offering amount
- $295K
- Amount sold
- $295K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$517KraisedJan 2018 · 18 investors · BiotechnologyRule 506(b)
▶$517KraisedJan 2018 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard LevinsonExecutive Officer, Director, Promoter
- William PerryExecutive Officer, Director, Promoter
- Robert BonczekDirector
- Ken GallDirector
- Robert IsaacsDirector
- Offering amount
- $800K
- Amount sold
- $517K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Deep Blue Medical Advances raised?
- Deep Blue Medical Advances has disclosed $18.1M raised across 6 rounds.
- Where is Deep Blue Medical Advances headquartered?
- Deep Blue Medical Advances is headquartered in Durham, US.